Urolume stent placement for the treatment of postbrachytherapy bladder outlet obstruction

Urology

Volumn 55, Issue 5, 2000, Pages 721-724

  Konety, Badrinath R ^a   Phelan, Michael W ^a   O'Donnell, Walter E ^a   Antiles, Leonard ^b   Chancellor, Michael B ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Montclair Urology Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BLADDER OBSTRUCTION; BRACHYTHERAPY; CLINICAL TRIAL; HUMAN; MALE; MIDDLE AGED; PROSTATE TUMOR; STENT;

AGED; AGED, 80 AND OVER; BRACHYTHERAPY; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; STENTS; URINARY BLADDER NECK OBSTRUCTION;

EID: 0034183256     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(00)00486-6     Document Type: Article

References (12)

1. Greenlee RT, Murray T, Bolden S, et al: Cancer statistics, 2000. CA Cancer J Clin 50: 7-33, 2000.
2. Holm HH, Pedersen JF, Hansen H, et al: Transperineal 1-125 iodine seed implantation in prostatic cancer guided by transrectal ultrasonography. J Urol 130: 283-286, 1983.
3. 125iodine implantation for treatment of clinically localized prostate cancer: 5-year tumor control and morbidity. Int J Radiat Oncol Biol Phys 43: 565-570, 1999.
4. Stock RG, Stone NN, DeWyngaert JK, et al: Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma. Cancer 77: 2386-2392, 1996.
5. Blasko JC, Ragde H, Schumacher D: Transperineal percutaneous iodine-125 implantation for prostatic carcinoma using transrectal ultrasound and template guidance. Endocurietherapy Hyperthermia Oncol 3: 131-139, 1987.
6. Weyrich TP, Kandzari SJ, Jain PR: Iodine 125 seed implants for prostatic carcinoma: five and ten year follow-up. Urology 41: 122-126, 1993.
7. Fowler JE, Barzell W, Hilaris BS, et al: Complications for 125-iodine implantation and pelvic lymphadenectomy in the treatment of prostate cancer. J Urol 121: 447-451, 1979.
8. Waterman FM, Yue N, Corn BW, et al: Edema associated with 1-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry: an analysis based on serial CT acquisition. Int J Radiat Oncol Biol Phys 41: 1069-1077, 1998.
9. Hu K, and Wallner K: Urinary incontinence in patients who have a TURP/TUIP following prostate brachytherapy. Int J Radiat Oncol Biol Phys 40: 783-786, 1998.
10. Wallner K, Lee H, Wasserman S, et al: Low risk of urinary incontinence following prostate brachytherapy in patients with a prior transurethral prostate resection. Int J Radiat Oncol Biol Phys 37: 565-569, 1997.
11. Blasko JC, Ragde H, and Grimm PD: Transperineal ultrasound-guided implantation of the prostate: morbidity and complications. Scand J Urol Nephrol Suppl 137: 113-118, 1991.
12. Terk MD, Stock RG, and Stone NN: Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate. J Urol 160: 1379-1382, 1998.